A detailed history of Seeyond transactions in Incyte Corp stock. As of the latest transaction made, Seeyond holds 85,621 shares of INCY stock, worth $5.19 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
85,621
Previous 83,180 2.93%
Holding current value
$5.19 Million
Previous $5.54 Million 24.07%
% of portfolio
0.67%
Previous 0.67%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$67.18 - $84.11 $163,986 - $205,312
2,441 Added 2.93%
85,621 $6.88 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $410,845 - $514,394
6,208 Added 8.07%
83,180 $5.54 Million
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $2.93 Million - $3.68 Million
44,236 Added 135.13%
76,972 $5.85 Million
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $64,369 - $77,717
-975 Reduced 2.89%
32,736 $2.6 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $467,892 - $547,450
7,387 Added 28.06%
33,711 $2.47 Million
Q3 2021

Nov 12, 2021

SELL
$68.67 - $84.02 $18,334 - $22,433
-267 Reduced 1.0%
26,324 $1.81 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $9,504 - $10,416
119 Added 0.45%
26,591 $2.24 Million
Q1 2021

May 14, 2021

SELL
$76.02 - $100.5 $393,327 - $519,987
-5,174 Reduced 16.35%
26,472 $2.15 Million
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $56,840 - $68,780
-704 Reduced 2.18%
31,646 $2.75 Million
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $780,432 - $1.01 Million
9,174 Added 39.58%
32,350 $2.9 Million
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $1.02 Million - $1.49 Million
13,722 Added 145.14%
23,176 $2.41 Million
Q1 2020

May 14, 2020

BUY
$63.18 - $85.97 $28,810 - $39,202
456 Added 5.07%
9,454 $1.11 Million
Q3 2019

Nov 13, 2019

BUY
$72.82 - $86.52 $115,710 - $137,480
1,589 Added 21.45%
8,998 $668,000
Q2 2019

Aug 13, 2019

BUY
$73.52 - $88.7 $363,924 - $439,065
4,950 Added 201.3%
7,409 $629,000
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $143,851 - $171,982
2,459 New
2,459 $156,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Seeyond Portfolio

Follow Seeyond and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.